GENB ▼ -4.4% - Generate Biomedicines, Inc.
$GENB reported Q3 2026 EPS of -$0.68, missing the -$0.54 estimate by 25.9%. Revenue of $4.2M missed the $7.8M estimate by 46.2%.
12-NOV-2026 07:55 AM ET
Share this post
More filings for $GENB
GENB ▼ -4.7% - Generate Biomedicines, Inc.Nov 12, 2026GENB - Generate Biomedicines, Inc. - SEC Filing Update (05-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 5, 2026GENB ▼ -1.9% - Generate Biomedicines, Inc.Oct 22, 2026GENB ▼ -7.4% - Generate Biomedicines, Inc.Oct 13, 2026GENB ▼ -8.2% - Generate Biomedicines, Inc.Oct 13, 2026GENB ▲ +0.3% - Generate Biomedicines, Inc.Oct 1, 2026
View full $GENB filing history →💬 Comments
Loading comments…
Leave a comment